Conductive Nanofibers-Enhanced Microfluidic Device for the Efficient Capture and Electrical Stimulation-Triggered Rapid Release of Circulating Tumor Cells

The effective detection and release of circulating tumor cells (CTCs) are of great significance for cancer diagnosis and monitoring. The microfluidic technique has proved to be a promising method for CTCs isolation and subsequent analysis. However, complex micro-geometries or nanostructures were often constructed and functionalized to improve the capture efficiency, which limited the scale-up for high-throughput production and larger-scale clinical applications. Thus, we designed a simple conductive nanofiber chip (CNF-Chip)-embedded microfluidic device with a herringbone microchannel to achieve the efficient and specific capture and electrical stimulation-triggered rapid release of CTCs. Here, the most used epithelial cell adhesion molecule (EpCAM) was selected as the representative biomarker, and the EpCAM-positive cancer cells were mainly studied. Under the effects of the nanointerface formed by the nanofibers with a rough surface and the herringbone-based high-throughput microfluidic mixing, the local topographic interaction between target cells and nanofibrous substrate in the microfluidic was synergistically enhanced, and the capture efficiency for CTCs was further improved (more than 85%). After capture, the sensitive and rapid release of CTCs (release efficiency above 97%) could be conveniently achieved through the cleavage of the gold-sulfur bond by applying a low voltage (-1.2 V). The device was successfully used for the effective isolation of CTCs in clinical blood samples from cancer patients, indicating the great potential of this CNF-Chip-embedded microfluidic device in clinical applications.

Automated summary

In this study, a simple conductive nanofiber chip (CNF-Chip) embedded microfluidic device with a herringbone microchannel was designed to achieve efficient capture and electrical stimulation-triggered rapid release of circulating tumor cells (CTCs). By utilizing the local topographic interaction between target cells and the nanofibrous substrate, along with the high-throughput microfluidic mixing, the capture efficiency for CTCs was significantly improved (over 85%). Additionally, the sensitive and rapid release of CTCs (release efficiency above 97%) could be achieved through the cleavage of the gold-sulfur bond by applying a low voltage (-1.2 V). This CNF-Chip embedded microfluidic device showed great potential in clinical applications, as it was successfully used for the effective isolation of CTCs in clinical blood samples from cancer patients.